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In the present study we conducted proteomic and pharmacological characterizations of
the venom extracted from the Brazilian tarantula Acanthoscurria paulensis, and evaluated
the cardiotoxicity of its two main fractions. The molecular masses of the venom compo-
nents were identiﬁed by mass spectrometry (MALDI-TOF-MS) after chromatographic
separation (HPLC). The lethal dose (LD50) was determined in mice. Nociceptive behavior
was evaluated by intradermal injection in mice and the edematogenic activity by the rat
hind-paw assay. Cardiotoxic activity was evaluated on in situ frog heart and on isolated frog
ventricle strip. From 60 chromatographic fractions, 97 distinct components were identi-
ﬁed, with molecular masses between 601.4 and 21,932.3 Da. A trimodal molecular mass
distribution was observed: 30% of the components within 500-1999 Da, 38% within 3500–
5999 Da and 21% within 6500–7999 Da. The LD50 in mice was 25.4  2.4 mg/g and the
effects observed were hypoactivity, anuria, constipation, dyspnea and prostration until
death, which occurred at higher doses. Despite presenting a dose-dependent edemato-
genic activity in the rat hind-paw assay, the venom had no nociceptive activity in mice.
Additionally, the venom induced a rapid blockage of electrical activity and subsequent
diastolic arrest on in situ frog heart preparation, which was inhibited by pretreatment with
atropine. In the electrically driven frog ventricle strip, the whole venom and its low
molecular mass fraction, but not the proteic one, induced a negative inotropic effect that
was also inhibited by atropine. These results suggest that despite low toxicity, A. paulensis
venom can induce severe physiological disturbances in mice.
© 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
According to the effects of venom in humans, accidents
caused by spiders can be categorized in, at least, two
distinct groups: those producing necrotic ulceration, andx: þ55 61 31073107.
script.
lsevier OA license.the ones that do not. Arachnidism produced by widow
spiders (Theridiidae) will result in systemic symptoms but
with minimal tissue damage. Envenomation by Agelenidae
family (araneomorph funnel-web spiders, including hobo
and grass spiders) results in severe tissue damage
(Mattiello-Sverzut et al., 1998; Elston et al., 2000) and, in
a minority of accidents, also systemic symptoms. Local
necrosis and systemic symptoms are observed in the events
incited by Sicariidae (Loxosceles; recluse and ﬁddlehead
spiders) (Madrigal et al., 1972; Barbaro et al., 1992).
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considered to be painful, but do not induce local necrosis or
systemic effects (Saucier, 2004). With exception of bites by
spiders of the genus Atrax (Hexathelidae), there are no
records of serious accidents caused by Mygalomorphae
spiders in human probably due to several factors such as
venom low toxicity to humans, insufﬁcient amount of
venom injected, greater difﬁculty of Orthognatans’ chelic-
erae in piercing the skin, and also because some species live
in low frequented local by man (Lucas, 2003). Unless
infection occurs, a slight inﬂammation at the puncture site
can arise. Spiders of the family Theraphosidae have urti-
cating hairs covering their bodies, which are brushed off by
the spider as a mechanism of defense to deter predators.
These hairs were found to induce local dermatitis in
vertebrates, including humans (Shrum et al., 1999). The
puncture wounds from the spider’s fangs require local
wound care, follow-up for signs of infection, short-term
analgesia and a tetanus booster (Kelley and Wasserman,
1998; Shrum et al., 1999).
The spider venom is a diverse mixture of low molecular
mass compounds (16% of all compounds), acylpolyamines
(11%), linear peptides (6%), cysteine-knotted mini-proteins
(60%), neurotoxic proteins (1%) and enzymes (6%) (Jackson
and Parks, 1989; Kuhn-Nentwig et al., 2011). It is mainly
used to paralyze prey and for defense, and contains toxins
that affect the central or peripheral nervous systems. These
neurotoxins have been identiﬁed mostly as acylpolyamines
and peptides or proteins that act onmembrane receptors or
ion channels (see review Estrada et al., 2007).
The acylpolyamine toxins are low molecular mass
compounds (<1 kDa) that appear to have evolved to
speciﬁcally provoke rapid paralysis. Their complex struc-
tures are composed by a polyamine chain with a primary
amino or a guanidine group at one end and an aromatic
ring at the other. These compounds interact with multiple
targets in the central and peripheral nervous systems of
insects, and also in the CNS of mammals, whereas the main
targets are ionotropic glutamate and nicotinic acetylcho-
line receptors (Kawai et al., 1982; Herold and Yaksh, 1992;
Bixel et al., 2001).
Eight hundred curated sequences of protein toxins have
been described for spider venom to date, among them
approximately 20% corresponds to Theraphosidae spiders
(available at ArachnoServer 2.0; Herzig et al., 2011). Most of
these 200 peptides has 30–40 amino acid residues, three
disulﬁde bridges and basic character (Escoubas and Rash,
2004), and are modulators of ion-channels, such as
calcium, sodium, and potassium.
In this communication we report the results of proteo-
mic and pharmacological characterizations of the venom
extracted from the Brazilian spider Acanthoscurria
paulensis.
2. Materials and methods
2.1. Spider collection
A. paulensis (Theraphosidae, Mygalomorphae) is a dark
brown colored spider widely distributed in three Brazilian
regions: South, Southeast and Midwest (Mello-Leitão,1923; Lucas et al., 2010). The specimens used in the
present work were collected in Brasília (Distrito Federal,
Brazil) under the “Instituto Chico Mendes de Conservação
da Biodiversidade” (ICMBio) license number 24227-1. Only
adult male specimens were used in this study due to their
availability in ﬁeld at the time. The spiders were identiﬁed
by Dr Paulo César Motta from the Laboratory of Arachnids
(University of Brasília, Brasília, DF, Brazil) based on
morphological characteristics.
2.2. Venom extraction and puriﬁcation
The venom of eight adult male specimens of A. paulensis
spiders was monthly obtained by electrical stimulation,
solubilized in deionized water containing 0.12% triﬂuoro-
acetic acid (TFA) and centrifuged at 10,000  g for 10 min.
The soluble supernatant was immediately frozen, lyophi-
lized and stored at 20 C. The venom dry weight was
determined in a high precision analytic balance. Aliquots of
5 mg of dried venom were solubilized in deionized water,
centrifuged at 10,000  g for 10 min and the supernatant
was submitted to high performance liquid chromatography
(HPLC), using a C18 reversed-phase semipreparative
column (Jupiter 5 mm, 300 A, 250  10 mm, Phenomenex)
using a linear gradient from solution A (0.12% TFA) to 60%
solution B (0.10% TFA in acetonitrile – ACN) run for 60 min
after 10 initialminutes at 0% solution Bwith detection at 216
and 230 nm. The fractions eluted at aﬂow rate of 1.5mL/min
were individually and manually collected, vacuum dried
and stored at 20 C until use. In order to obtain the low
molecular mass fraction (LMMF) and protein fraction (PF)
for the evaluation of cardiotoxic activity, the fractions
eluting from 0 to 35% solution B and from35 to 74% solution
Bwere separately collected. After removal of solvent, LMMF
and PF were quantiﬁed by dry weight in a high precision
analytic balance and stored at 20 C until use.
2.3. Mass spectrometry
The molecular masses of the chromatographic fractions
of A. paulensis venom were performed on an UltraFlexIII
MALDI-TOF/TOF mass spectrometer (Bruker Daltonics,
Germany). The samples were reconstituted in deionized
water at variable concentrations and dissolved (1:3, v:v)
in an a-cyano-4-hydroxycinnamic acid matrix solution
(a-cyano-4-hydroxycinnamic acid at 5 mg/mL dissolved on
acetonitrile, water, triﬂuoroacetic acid, 5:4:1, v:v:v) spotted
in triplicate onto a sample plate and allowed to dry at room
temperature. The MS spectra were acquired in both re-
ﬂected and linear positive modes. Calibration of the system
was performed using a mixture of the Peptide Calibration
Standard and Protein Calibration Standard I for mass
spectrometry (Bruker Daltonics, Germany). Spectra were
processed with MassLynx 3.5 (Manchester, UK) and
FlexAnalysis 3.3 (Bruker Daltonics, Germany).
2.4. Animals
Animals were contained in accordance with the ethical
guidelines of the Brazilian Society for Neuroscience and
Behavior, which follows the guidelines for animal care
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Animal Resources, National Research Council, U.S.A. This
study was approved by the Committee for Ethics in Animal
Use of the Institute of Biological Sciences, University of
Brasília, under license numbers 73742/2008 and 127103/
2011. Likewise, every effort was made to avoid unnecessary
stress and pain to the experimental animals. The number of
animals was kept to the minimum necessary to test the
concept. The experimental animals used in this study were
Swiss albino mice (Mus musculus) of approximately 26–
30 g, Wistar rats (Rattus norvegicus) of 150–200 g, and frog
(Lithobates catesbeianus).
2.5. Lethality assay (LD50)
The toxicity of A. paulensis venom was evaluated by
determining the 50% lethal dose (LD50) in mice, the dose
able to kill 50% of animals tested. Four experimental groups
were tested with different doses of venom: 20, 25, 30 and
40 mg/g of mice (n ¼ 5/group). The venomwas dissolved in
100 mL saline solution (150 mM NaCl) and injected by i.p.
route. The control group (n ¼ 5) was injected with saline.
The lethality rate of animals was observed 48 h after
inoculation of venom or saline. At the end of the experi-
ment, the surviving animals were euthanized with an
overdose of sodium pentobarbital (about 75 mg/kg). The
values for the lethality assay and their conﬁdence limits
were calculated by Probit analysis (Finney, 1971), using the
software BioStat 5.8.4 version 2009.
2.6. Determination of venom effects
The venom of the A. paulensis spider was evaluated for
its ability to induce behavioral and physiological changes in
mice. All animals used in the lethality assay were observed
during the ﬁrst hour of the experiment, and the symptoms
were identiﬁed as described in Table 1.
2.7. Morphological analysis
All mice utilized in the lethality assay were dissected
and their heart, lung, kidney, liver and spleen wereTable 1
Changes observed in mice (n ¼ 5/group) during 150 min after i.p. injection of di
Changes Deﬁnition
Abdominal spasms Involuntary contraction of abdominal muscles
Abdominal writhing To move with a twisting or contorted motion
Anuria Decreased or no urine production
Ataxia Staggering accompanied by postural imbalance
Complete ﬂaccid
paralysis
Loss of muscles tonus and motor weakness
Constipation Infrequent bowel movement (3 times or less per week
Cyanosis Bluish color of the skin and the mucous membrane
Death Deﬁnitive cease of all physiological activities
Dyspnea Difﬁculty breathing
Hypoactivity Reduction of normal movements of the animal
Prostration Weakness and loss normal mobility
Seizures Muscle contraction disorganized, violent and generaliz
Tachycardia Rapid heart rate
Throes Involuntary contraction and sudden of small muscle grremoved, ﬁxed in 10% buffered formalin and embedded in
parafﬁn (Prophet et al., 1992). Histological sections (4 mm
thick) were stained with hematoxylin eosin (HE) and
analyzed under a light microscope (Axioskop-2, Zeiss,
Germany). The tissues of animals injected with A. paulensis
venomwere compared with the tissues of animals injected
with saline solution, and any changes were considered.
2.8. Evaluation of nociceptive behavior
The nociceptive behavior was evaluated by the intra-
dermal injection in mice. The assay was preformed similar
to formalin test, in which two phases can be observed:
Phase I (0–10 min) is referred as the acute phase and the
Phase II (10–50 min) is associated with local release of
endogenous mediators, which generate local inﬂammatory
response (for review, see Le Bars et al., 2001). Twenty-eight
mice (n ¼ 5–6/group) were used. Three experimental
groups were subcutaneously injected through intraplantar
route into the left hind-paw with different doses of crude
venom (5, 10 and 20 mg/paw). The venom was dissolved in
saline solution (150 mM NaCl), and the injection volume
was 50 mL. The positive control mice received 50 mL of 2.5%
formalin and the negative one 50 mL saline solution through
the same route of administration. After injections, each
mouse was placed in a transparent glass cage, and the
amount of time the animal licked, bit or shook the injected
paw was determined between 0 and 10 min (ﬁrst phase)
and 10 and 50 min (second phase). After assays, mice were
immediately euthanized with sodium thiopental (75 mg/
kg). These results were submitted to analysis of variance
(ANOVA) followed by the Tukey test, using GraphPad Prism
software version 5.0. Differences were considered signiﬁ-
cant at values of p < 0.05.
2.9. Edematogenic activity on rats
To evaluate the edematogenic activity of A. paulensis
venom, rat paw edema was measured with a manual
hydroplethysmometer as described earlier (Mortari et al.,
2012). After a subplantar injection of 50 mL of A. paulensis
venom (20, 40 and 60 mg/paw) on the right hind-paw offferent doses of A. paulensis spider venom.
Occurrence of the change (%) after injection of different
venom doses (in mg/g mice)
20 25 30 40
0 100 20 0
0 0 40 0
0 100 0 100
0 100 100 100
0 100 0 100
) 100 100 100 100
0 0 0 100
0 60 80 100
100 100 0 100
100 100 0 100
0 100 20 100
ed 0 0 0 100
0 0 0 100
oups 0 0 0 100
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paw edema was determined every 10 min in the ﬁrst hour
and every 30min in the second hour. The left hind-pawwas
injected with 150 mM NaCl to serve as control. Data was
tested by two-way ANOVA followed by the Bonferroni post-
test (p < 0.05 and p < 0.001).
2.10. Cardiotoxic activity on in situ frog heart
Frogs (L. catesbeianus) were initially anesthetized with
2% lidocaine chloride through the foramen magnum and
then decerebrated by transection of the brain at the level of
mid-diencephalon. The scapulae were excised unilaterally
to approach the vagus nerve, which was, when required,
stimulated (6 V, 10 Hz, 0.5 ms) by a pair of electrodes
connected to the stimulator (S48 Stimulator, Grass Instru-
ment Division). The abdominal cavity was opened, the
dorsal vena cava cannulated, and the apex of the ventricle
of the exposed heart was attached by ametal hook to a F-60
myograph (Narco Bio-Systems). Both mechanic and electric
responses of the spontaneously beating heart were recor-
ded simultaneously as described (Schwartz et al., 1999).
The responses were recorded for 3 min after vagal stimu-
lation and after crude venom (500 mg) administration
through the cannula implanted in the posterior vena cava.
The potential blocking action of atropine upon vagal stim-
ulation or crude venom administration (500 mg) was tested
by previous injection of the muscarinic blocker (2 mg) and
data recorded for 3 min. Compounds were injected in the
vena cava in a total volume of 200 mL Ringer solution
(in mM: 111 NaCl, 1.9 KCl, 1.1 CaCl2, 2.4 NaHCO3, 10 glucose,
pH 7.2).
2.11. Isolated frog ventricle strip
The frog was immobilized as described above. The heart
was removed and the ventricle was dissected from isolated
heart in aerated glucose added Ringer at room tempera-
ture. The ventricle strips (about 3 mm) were individually
transferred to a chamber containing 2.0 mL Ringer solution,0 40 20 
0 
750 
1500 
Time (mi
m
A
b
s
 
2
1
6
n
m
 
1 
2 
5 
6 7 
11 
9 
15 
14 
16 
13 
17 
20 
22 23 
2
2
10 30 
Fig. 1. Chromatographic proﬁle of 5.0 mg of Acanthoscurria paulensis soluble venom
using a gradient of acetonitrile (ACN) that is represented by the dashed line, with
numbered.and were electrically driven with square pulses of 2.0 ms
duration, 0.15 Hz frequency and the lowest voltage that
induced maximum contractions (20 V) (S48 Stimulator,
Grass Instrument Division). The rate and strength of
contraction were registered with the F-60 transducer and
a recorder (Narco Bio-Systems). Acetylcholine (0.25 mg),
atropine (2 mg), crude venom (50 mg), PF (50 mg) and LMMF
(12.5 mg) were removed from the bath through washing it
10 times between the experiments. Data was analyzed by
ANOVA and Tukey post-test (p < 0.05).
3. Results
3.1. Venom composition
The fractionation of A. paulensis venom by RP-HPLC
yielded a total of 60 chromatographic fractions (Fig. 1).
From these, 97 distinct components were identiﬁed by
MALDI-TOF MS analysis, with molecular masses varying
from m/z 601.4 to 21,932.3. Analysis of the molecular
masses obtained by mass spectrometry mapping of A.
paulensis venom reveals the presence of three main groups
of molecular mass components (Fig. 2), with 30% of the
components within the range of 500 and 1999 Da and 38%
within the range of 3500 and 5999 Da. A third group
distributes from 6500 to 7999 Da, with about 21%. The
elution proﬁle (% acetonitrile) vs. the molecular masses
found in the venom is presented in Fig. 3. Low molecular
mass compounds (<1 kDa) are present in most of the
analyzed fractions. The ions m/z 601.4 and 729.6 were
detected in abundance in the most hydrophilic fractions
but were also found spread over many elution fractions.
Peptides withmolecular masses greater than 2000 Dawere
observed only from the 34th fraction analyzed (37% ACN),
both in reﬂected (500–6000 Da) and linear (3.5–15 kDa and
10–40 kDa) modes. Considering that, for cardiotoxicity
evaluation, the fractions eluting from 0 to 35% ACN and
from 35 to 74% ACN were separately collected and named,
respectively, low molecular mass fraction (LMMF) and
protein fraction (PF).80 60 
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Fig. 2. Frequency of molecular masses of chromatographic fractions obtained from A. paulensis venom. The 97 different molecular masses were distributed in
500 Da classes, with an interval from 500 to 25,000 Da. Data obtained from analysis in MALDI-TOF/TOF MS, operating in positive reﬂected and linear modes, with
a-cyano-4-hydroxycinnamic acid as matrix solution.
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analysis
The lowest venomdose (20mg/g ofmice) didnot produce
any mortality, but caused hypoactivity, prostration,
writhing, dyspnea, ataxia and constipation. At intermediary
doses (25 and 30 mg/g), besides the effects already observed
at the lowest dose, abdominal spasms, anuria, and general
ﬂaccid paralysis were also noticed, leading to death 60% and
80% of animals, respectively. In the highest dose (40 mg/g of
mice), all animals presented also spasms, cyanosis, tachy-
cardia, seizures (5 min after injection) and death in about
90min after the beginning of the experiment. The LD50 of A.
paulensis venom (25.4  2.4 mg/g or 763.5 mg/mice of 30 g)
was estimated by the Probit analysis method (Fig. 4).
The behavioral and physiological effects observed in
mice during the ﬁrst 150 min after i.p. injection of A. pau-
lensis venomwere abdominal spasms, abdominal writhing,
anuria, ataxia, complete ﬂaccid paralysis, cyanosis, con-
stipation, dyspnea, hypoactivity, prostration, seizure,
tachycardia, throes and death as speciﬁed in Table 1.0.0
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Fig. 3. Molecular mass distribution of the compounds present in A. paulensis veno
obtained by RP-HPLC as cited before. Data acquired by MALDI-TOF/TOF MS analysis
a-cyano-4-hydroxycinnamic acid as matrix solution. The bars refer to the low mole
fractions separately collected and used in the ventricle strip assay.No morphological alterations were observed in tissues
(heart, lung, kidney, liver and spleen) from mice injected
with any dose of A. paulensis venom (20, 25, 30 and 40 mg/g
of mice) (data not shown).
3.3. Evaluation of nociceptive behavior
In both phases of the nociception test, at the doses
tested (5, 10 and 20 mg/mice hind-paw), A. paulensis venom
did not induce nociceptive behavior in mice when
compared to the control (saline). In addition, all experi-
mental groups and saline control were signiﬁcantly
different from the formalin group in the ﬁrst and second
phases [F(4,23) ¼ 189.30 and F(4,23) ¼ 16.95, p < 0.0001,
respectively] (Fig. 5).
3.4. Edematogenic activity
Subplantar injection of A. paulensis crude venom caused
a dose-dependent rat hind-paw edema compared to that
observed in the saline-injected contralateral paw (Fig. 6). In40 50 60 70 80
etonitrile
FP
m depending on their HPLC elution proﬁle. Chromatographic fractions were
operating in positive reﬂected and linear modes, from 500 to 25,000 Da, with
cular mass fraction (LMMF) and protein fraction (PF) compounds, being both
Fig. 4. Dose-response curve obtained from i.p. injection of A. paulensis
spider venom in mice. R2 ¼ 0.9618.
Fig. 6. Volume of the rat paw edema obtained by subplantar injection of
A. paulensis venom. Results are expressed as percentages of rat paw volume
increase in relation to baseline data obtained before injection. The points
represent mean  SEM (n ¼ 6/group) at three different venom doses (20, 40
and 60 mg/paw) and control group (saline), injected in a ﬁnal volume of
50 mL in the right and left rat hind-paw, respectively. Data was analyzed by
ANOVA followed by the Bonferroni post-test. *p < 0.05 compared to saline,
#p < 0.05 compared to 20 mg/paw dose, þp < 0.05 compared to 40 mg/paw
dose.
C.B.F. Mourão et al. / Toxicon 61 (2013) 129–138134a two-way ANOVA test, signiﬁcant differences in the effect
of treatment [F(3,35) ¼ 41.06; P < 0.0001], time
[F(7,35) ¼ 6.46; P < 0.0001] and treatment-vs.-time inter-
action [F(21,245) ¼ 1.679; P < 0.001] were observed. Post
hoc analysis indicated that highest doses of A. paulensis
crude venom (60 and 40 mg/paw) induced an edematogenic
effect that was observed during thewhole experimentation
period. Moreover, at the periods of 40, 90 and 120 min after
venom injection, signiﬁcant differences between the
highest doses and the lowest (20 mg/paw) were observed.
3.5. Cardiotoxic activity
The evaluation of the records obtained in the in situ frog
heart showed transient cardiac arrest produced by vagal
stimulation and after administration of venom (500 mg)
(Fig. 7). The vagal stimulation led to a reduction on the
contraction force (negative inotropic effect) and heart rate
(negative chronotropic effect), well-known effects medi-
ated by the release of acetylcholine (ACh) from para-
sympathetic autonomic nerve terminals. These effects were
reversible within 30 s. The crude venom also produced
negative chronotropic and inotropic effects, causing cardiacFig. 5. Nociceptive behavior in mice after A. paulensis spider venom injec-
tion. The points represent mean  SEM (n ¼ 6/group) at three different
venom doses (20, 10 and 5 mg/paw), vehicle and formalin groups, injected in
a ﬁnal volume of 50 mL in the left mice hind-paw. Nociceptive behavior in
the ﬁrst phase (0–10 min after the injection) and the second phase (10–
50 min after the injection) was scored as the amount of time spent licking
the injected hind paw. Data was analyzed by ANOVA followed by the Tukey
post-test. *p < 0.05 compared to vehicle, þp < 0.05 compared to 5 mg/paw
dose, #p < 0.05 compared to 10 mg/paw dose, $ p < 0.05 compared to 20 mg/
paw dose.arrest, which was reversible in about 2 min. The vagal
stimulation effect was completely blocked in the presence
of atropine (2 mg), a muscarinic receptor blocker. By adding
crude venom (500 mg) in the heart pretreated with atro-
pine, no changes in the electrical register were observed,
indicating the blockade by atropine. The brief destabiliza-
tion in the mechanical register could be explained by the
Frank–Starling mechanism, which illustrates the ability of
the vertebrate heart to intrinsically modulate the rate and
strength of cardiac muscle contractility in response to
changes in atrial pressure driven by changes in venous
return (da Silva et al., 2011).
The assay with the isolated frog ventricle strips
conﬁrmed the results obtained in the heart in situ (Fig. 8).
The crude venom (50 mg) caused a reduction in the strength
of ventricle slice contraction (negative inotropic effect)
similar to that produced by acetylcholine (0.25 mg). The
same effect was reproduced with the “low molecular mass
fraction – LMMF” (12.5 mg), but not with the “protein
fraction – PF” (50 mg). The administration of atropine (2 mg)
to the bath caused a mild positive inotropic effect, which
remained after administration of ACh, crude venom or
LMMF. In the presence of atropine, the effects of these were
no longer observed. The records of ACh (0.25 mg) and LMMF
(12.5 mg) in presence of atropine (2 mg) were equal to that of
“atropine plus venom”, shown in Fig. 8A, and therefore are
not illustrated. Fig. 8B shows the reduction rate of muscle
contraction obtained for each treatment. Statistically, the
crude venom, LMMF and acetylcholine had similar negative
inotropic effects. The protein fraction (PF) conversely did
not show this effect.
4. Discussion
Commonly, during the chromatographic separation of
spider venom by RP-HPLC, the acylpolyamines and other
low molecular mass compounds elute in the ﬁrst more
hydrophilic chromatographic steps (Kitaguchi and Swartz,
2005; Estrada et al., 2007). Most venom peptides that
modulate the activity of ion channels elute between 35 and
Fig. 7. Effect of A. paulensis venom on the isolated frog heart in situ. Force generation and electrical activity (EA) were recorded during control perfusion with
Ringer solution and after vagal stimulus (6 V, 10 Hz, 0.5 ms), crude venom administration (500 mg) or these same treatments after atropine administration (2 mg).
The compounds were administered in the posterior vena cava in a total volume of 200 mL. Arrows indicate the start of treatment.
C.B.F. Mourão et al. / Toxicon 61 (2013) 129–138 13545% acetonitrile, while higher molecular mass proteins,
including enzymes, elute at higher acetonitrile concentra-
tions (Horni et al., 2001; Guette et al., 2006; Estrada et al.,
2007). For this reason, and based on the present mass
spectrometry mapping, two main venom component
groups were separately collected: the fraction of low
molecular mass (LMMF) from 10 to 45 min (0–35% ACN),
and protein fraction (PF) from 45 to 74 min (35–74% ACN).
The molecular mass distribution proﬁle of the A. paulensis
venom components was trimodal, differently from the
bimodal proﬁle obtained for the venom of 55 spiders’
species by Escoubas and Rash (2004), in which most of the
compounds (57.8%) had between 3500 and 4500 Da, and
a lower amount (6.9%) was in a secondary distribution,
6500–7000 Da.
The ions m/z 601.4 and 729.6, found in abundance in A.
paulensis venom, correspond to those observed in the
venom of Lasiodora parahybana (m/z 601.38 and 729.35), inFig. 8. Effect of A. paulensis venom and venom fractions on frog heart ventricle str
solution and after treatment with acetylcholine (ACh, 0.25 mg), crude venom (Venom
12.5 mg). All treatments were repeated in the presence of atropine (2 mg), being equa
stimulus of 20 V, 0.15 Hz and 2.0 ms duration. Each treatment was performed at le
contraction obtained after treatments. Bars represent the mean  SEM (n  2/treat
compared to ACh, #p < 0.05 compared to venom, þp < 0.05 compared to LMMF.juveniles (4 years old), adults (8 years) and older spiders
(14 years), being considered as biomarkers (Guette et al.,
2006). Skinner et al. (1990) partially characterized these
two acylpolyamines, named Apc600 and Apc728, from the
venom of the tarantula Aphonopelma chalcodes.
Despite the reputation of spiders, there are few reports
of bites by these animals, most of them result in mild to
severe pain, itching and increased sensitivity, which may
persist for several hours after the bite, swelling, redness,
joint stiffness and swelling of limbs, burning and cramping.
In more severe cases, strong cramping and muscle spasms
which can last several hours can also be observed. The pain
after the bite may be due to a combination of mechanical
damage due to large chelicerae, low pH venom (usually
close to 5) and effect of biogenic amines (serotonin and
histamine), adenosine and ATP (Escoubas and Rash, 2004).
These spiders are traded as pets and world widely kept and
bred in captivity (de Haro and Jouglard, 1998), so accidentsips. (A) Force generation was recorded during control perfusion with Ringer
, 50 mg), protein fraction (PF, 50 mg) and low molecular mass fraction (LMMF,
l to “atropine þ venom” shown above. The ventricle strips received electrical
ast twice. Arrows indicate the treatment time. (B) Reduction rate of muscle
ment). Data was analyzed by ANOVA followed by Tukey post-test. *p < 0.05
C.B.F. Mourão et al. / Toxicon 61 (2013) 129–138136can potentially occur with some frequency. As far as we
know, there are no reports of human deaths caused by
accidents with Theraphosidae spiders worldwide. On the
other hand, some studies have demonstrated signiﬁcant
toxicity of Theraphosidae venoms in various animals,
including rats, mice, cats, birds and dogs (Bucherl, 1971;
Bettini and Brignoli, 1978; Atkinson, 1993). There are
several reports of canine and feline fatalities provoked by
Australian theraphosid spiders, such as Selenocosmia spp.
(Robinson and Grifﬁn, 1985; Raven, 2000).
There are few quantitative studies reporting the toxicity
of the spider venom. A comparative study in mice using the
crude venom of 55 spiders’ species revealed considerable
toxicity differences, with time to death ranging from 3 min
to more than 2 h and symptoms involving rigid or ﬂaccid
paralysis, piloerection, lacrimation and excessive salivation,
hyperextension of the tail and seizure (Escoubas and Rash,
2004). The venom toxicity was higher for Asian and African
species, and for arboreal ones such as Heteroscodra, Stro-
matopelma, and Poecilotheria species. Among the 20 South
American species, 12 of them, including Grammostola
spatulata and Acanthoscurria sp., showed higher venom
toxicity leading to death in less than 30 min (Escoubas and
Rash, 2004).
The LD50 value of A. paulensis venom, when injected
intraperitoneally in 30 g mice, was 25.4  2.4 mg/kg, with
a clear dose-dependence, and death occurred in approxi-
mately 2 h.
It has been reported for Acanthoscurria musculosa a LD50
of 7.5 mg/kg when intravenously inject into mice (Bucherl,
1971). The LD50 calculated after intravenous injection of the
venom of the tarantula Stromatopelma griseipeswas 8.1 and
9.5 mg/kg for young female and adult male spiders,
respectively (Célérier et al., 1993). Quantitative comparison
with previous studies is challenging, since the toxicity
varies with the route of venom administration and the time
considered. The A. paulensis venom seems to be less toxic
than other tarantula venoms (Bucherl, 1971; Célérier et al.,
1993). However, it is important to consider the adminis-
tration route used to determine the LD50 value. This venom
toxicity might be higher, with maybe different observed
symptoms, if it was administered by intravenous or intra-
cerebroventricular route, and not by intraperitoneal route,
as it was done.
Even so, considering the LD50 obtained for A. paulensis
venom and the absence of serious accidents reported with
its bite, it is assumed that this spider is not of clinical
importance for humans. Even though the trials using mice
and other nonhuman animals are essential tools for toxicity
studies, differential toxicity in mammals can lead to
incorrect extrapolations. The venom of Australian Atrax
robustus is highly toxic and potentially lethal to humans,
but has almost no effect in most non-primates, including
rodents and domestic animals such as dogs (Sutherland
and Tibballs, 2001). In contrast, Phlogiellus spp. and Sele-
nocosmia spp. venoms are fatal to dogs, but have little effect
in humans (Isbister et al., 2003).
Among the symptoms described for Theraphosidae
spider bites the most common is the severe pain. The
intradermal injection in mice was used to investigate the
nociceptive response induced by A. paulensis venom effectson pain. In the formalin test, the ﬁrst phase is thought to
result from direct activation of primary afferent sensory
neurons, whereas the second phase has been proposed to
reﬂect the combined effects of afferent input and central
sensitization in the dorsal horn (for review see Le Bars et al.,
2001). The ﬁrst and second phases of this response are
associated with direct activation of transient receptor
potential ankyrin (TRPA)-1 receptors present in nociceptors
(McNamara et al., 2007). The second phase is also associ-
ated with the development of an inﬂammatory response
triggered by many mediators such as IL-1b, IL-6, IL-8 and
TNF-a (Chichorro et al., 2004), eicosanoids and NO
(Hunskaar and Hole, 1987; Moore et al., 1991), which
prolongs the pain for the measurement remainder time
(Shin et al., 2011).
At the doses tested (5, 10 and 20 mg venom/paw), the
venom did not produce a signiﬁcantly effect on nociception
test. Although inﬂammatory responses have been observed
in the paw edema test, it is worth speculating that the
venom in larger doses (>20 mg venom/paw) could induce
painful response. In fact, 20 mg venom/paw was able to
induce hind-paw edema after 10 min of administration.
Phoneutria nigriventer (Costa et al., 2001; Zanchet and Cury,
2003) and Loxosceles gaucho (Barbaro et al., 2010) venoms
and peptides isolated from Scaptocosa raptoria venom
(Ferreira et al., 1998) also produced edema in rodents.
These studies showed that pain and swelling caused by
these spider venoms are related, as they involve the same
molecular cascades.
The cardiotoxic activity of A. paulensis venom and its two
chromatographic fractions, LMMF and PF, was evaluated by
two assays: in situ frog heart and frog heart ventricular
slices. In both, the venom induced cardiac arrest inhibited
by atropine, suggesting the dependence of acetylcholine
receptor activation. Only the LMMF was able to produce
similar response, indicating the venom peptides are not
responsible for it. The venom of the tarantula spider Lasio-
dora sp. caused a dose-dependent bradycardia, a transient
cardiac arrest and rhythmdisturbanceson isolated rat heart,
effects that were enhanced by anticholinesterase drugs,
abolished by atropine, inhibited by an inhibitor of ACh
vesicular transport, and not modiﬁed by TTX, leading the
suggestion that this venom induces the release of ACh from
parasympathetic nerve terminals by activating TTX-
resistant Naþ-channels (Kalapothakis et al., 2003). The
dialyzed P. nigriventer venom produced positive inotropic
and chronotropic effects in isolated rat heart that were
inhibited by b-adrenergic antagonists and potentiated by
atropine (Costa et al., 1998). In a previous study, P. nig-
riventer whole venom induced negative chronotropic and
inotropic effects on isolated guinea pig atria, these effects
being abolished by atropine (Vital-Brazil et al., 1988). While
the sympathetic effect is explained by the presence of
venom neurotoxins able to modulate Naþ-channel activity,
the parasympathetic response is probably mediated by the
presence of biogenic amines in the venom, which were
excluded by venom dialysis (Costa et al., 1998). In the
present study, it was shown that the parasympathetic-like
response produced by A. paulensis venom is also due to
low molecular mass compounds, possibly biogenic amines
also or polyamines. Alternatively, LMMF component(s),
C.B.F. Mourão et al. / Toxicon 61 (2013) 129–138 137eluting in more hydrophilic fractions, might induce the
release of acetylcholine from parasympathetic nerve
terminals, resulting in the negative inotropic effect
observed.
In conclusion, the A. paulensis venom proteomic and
pharmacological proﬁling was presented for the ﬁrst time.
By means of chromatography and mass spectrometry the
venom compounds variability was showed, which featured
60 chromatographic fractions and 97 different compo-
nents. Noteworthy are the lowmolecular mass compounds,
such as 601.4 and 729.6 Da which are putative acylpoly-
amines, in addition to many peptide components, among
which 60% are between 3500 and 7999 Da. LD50 was
deﬁned and is in accordance to the values reported for
tarantula spiders, which generally do not provoke severe
envenoming. Despite that, A. paulensis venom induced
many behavioral and physiological changes in mice, and
edematogenic activity in rats. An inotropic effect produced
on frog heart is probably due to the low molecular mass
compounds present in the more hydrophilic fractions of
venom that may act either by inducting the release of
acetylcholine from parasympathetic terminals or by
directly acting as a cholinergic agonist.
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